Fri.Jan 03, 2025

article thumbnail

CARsgen gets a win for CAR-T in solid tumours

pharmaphorum

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

90
article thumbnail

FDA approves Sequana Medical’s Alfapump for ascites treatment

PharmaTimes

FDA gives green light to innovative device for liver conditions

FDA 85
article thumbnail

Capricor files cell therapy for DMD cardiomyopathy with FDA

pharmaphorum

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.

FDA 90
article thumbnail

5 Notable Health Tech Funding Announcements in December

MedCity News

Health tech companies made several major funding announcements in December. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in December appeared first on MedCity News.

84
article thumbnail

Enterprise ABM Marketing Tools: A Marketer's Guide

Savvy B2B marketers know that a great account-based marketing (ABM) strategy leads to higher ROI and sustainable growth. In this guide, we’ll cover: What makes for a successful ABM strategy? What are the key elements and capabilities of ABM that can make a real difference? How is AI changing workflows and driving functionality? This Martech Intelligence Report on Enterprise Account-Based Marketing examines the state of ABM in 2024 and what to consider when implementing ABM software.

article thumbnail

NHS Confederation welcomes social care commission announcement

PharmaTimes

Government announces independent commission on social care

article thumbnail

Patient organisations 'too influenced by corporate funders'

pharmaphorum

Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on corporate funding.

More Trending

article thumbnail

How pharma was instrumental in President Jimmy Carter’s global health efforts

PharmaVoice

Pharma companies stepped up to support The Carter Center and provide access to life-saving treatments.

Pharma 64
article thumbnail

HPLC method demonstrates value for quality control analysis of cardiovascular drug

European Pharmaceutical Review

Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its

article thumbnail

Regeneron builds in eye disease tech with Oxular takeover

pharmaphorum

Regeneron has bought Oxular, a UK specialist in retinal diseases, in a move that bolsters its already strong position in ophthalmology therapies.

62
article thumbnail

Expanding diagnostic and biomarker options to improve MASH clinical trials

Pharmaceutical Technology

Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses and clinical trials.

59
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

FDA Releases Draft Guidance on Sampling and Testing of In-Process Materials and Drug Products

PharmaTech

The draft guidance document provides recommendations for complying with 21 CFR 211.110.

FDA 59
article thumbnail

Navigating Access and Reimbursement Through Uncertainty

Pharmaceutical Commerce

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

59
article thumbnail

SIGA’s antiviral approved in Japan for orthopoxvirus treatment

Pharmaceutical Technology

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

59
article thumbnail

Pharma Pulse 1/3/25: Navigating Fertility Misinformation on Social Media, Nearly 75% of Adolescents Experience Depression/Anxiety & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 59
article thumbnail

4 AI Hacks to Make Sales Teams More Efficient

Over the last two years, there’s been a 76 percent increase in AI adoption across sales organizations. The reason for its rise? AI increases teams’ productivity by predicting and automating actions that require manual effort. In other words, the research that takes reps hours, AI can do in seconds. For sales teams, AI opens up a world of new possibilities, including automating outreach, identifying best-fit buyers, and keeping CRMs flush with fresh data.

article thumbnail

From Davids to Goliaths: the GLP-1R gold rush

Pharmaceutical Technology

There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

article thumbnail

Sanofi, SK Bioscience Launch Phase III Trial Program to Develop PCV21 for Pneumococcal Conjugate Vaccines

PharmExec

PCV21 is the first pneumococcal conjugate vaccine candidate with more than 20 serotypes to enter a Phase III clinical trial in infants and toddlers.

52
article thumbnail

China’s NMPA prioritises HUTCHMED’s lung cancer therapy review

Pharmaceutical Technology

China NMPA has granted acceptance and priority review for the NDA for HUTCHMEDs ORPATHYS (savolitinib) and TAGRISSO (osimertinib) combination

59
article thumbnail

Johnson & Johnson, Kaken Pharmaceutical Strike Licensing Agreement for the STAT6 Program That Targets Autoimmune, Allergic Diseases

PharmExec

Under terms of the deal, Johnson & Johnson will gain an exclusive license to the STAT6 program, with Kaken maintaining commercialization rights in Japan.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Peer Exchange: The Future of RFID and Supply Chain Management (Episode 6)

Pharmaceutical Commerce

In the final part of this roundtable discussion, a panel of subject matter experts discuss what the future holds for this technology, why end-to-end visibility is necessary in healthcare, and the opportunities for greater RFID adoption that lie ahead.

article thumbnail

Biotech in the Empire State: Building a World-Class Bioscience Ecosystem in New York

PharmExec

Jennifer Hawks Bland, CEO of NewYorkBIO, shares her journey from litigation to biotech leadership, discusses fostering innovation in New York's thriving bioscience ecosystem, and outlines her vision for the state as a global biotech hub.

52
article thumbnail

Roche Forms Partnership Worth Potentially More than $1 Billion with Innovent to Develop Novel ADC for SCLC

PharmaTech

Under the agreement, the companies will advance development of IBI3009, Innovents ADC candidate, which has received IND approvals in the US, China, and Australia.

52
article thumbnail

Zepbound Expected to Surpass Wegovy in Weight Loss Market, New Report States

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

How to Create Sales Email Sequences That Convert

Modern go-to-market teams know it takes more than one email to break through the noise. Multiple touchpoints means more ways to get your pitch right — and, potentially, more ways to be wrong. The good news? Once you know how to write compelling, one-off emails to entice prospective customers, you can easily do the same across a short sequence of emails.

article thumbnail

London-listed Poolbeg discussing Hookipa merger

pharmaphorum

The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.

Pharma 52
article thumbnail

As Healthcare and Technology Intersect, Why Are Strong Communication Skills Crucial for Today and Tomorrow?

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

Creating a Sustainable Approach

PharmaTech

In an interview with Pharmaceutical Technology Roger Viney from ICE Pharma highlights the importance of sustainability for the bio/pharma industry and some important future considerations for companies.

Pharma 52
article thumbnail

FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024

PharmaVoice

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Announces Reopening of Comment Period Regarding HCP Immunogenicity Risk from Follow-on Recombinant Peptides

PharmaTech

The comment period for the Federal Register Notice, Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-on Recombinant Peptide Products: Establishment of a Public Docket: Request for Information and Comments, has been reopened by FDA until March 3, 2025.

FDA 52
article thumbnail

Pharma Pulse 1/3/25: Physician Engagement and Tackling Health-Related Social Needs, Can Pain Be Patched Up? & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

ASHP Midyear: New Therapies Are on the Horizon for Fatty Liver Disease, But Access Challenges Remain

Pharmacy Times

New medications like GLP-1 agonists and resmiterone show promise in reversing fatty liver disease and preventing progression.

Medical 48
article thumbnail

Zephound Expected to Surpass Wegovy in Weight Loss Market, New Report States

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

Foundational ABM Building Blocks

Account-based marketing (ABM) is a key strategy for driving sustainable growth. Today, many B2B companies use ABM teams or technologies to make sales. But getting a program off the ground successfully doesn’t have to be a daunting task. Watch this webinar with Rachael Foster, Director of Account-Based Experience at ZoomInfo, and Dan Dolph, Manager of Account-Based Experience at ZoomInfo.